FIELD: medicine.
SUBSTANCE: invention relates to treatment of the acute stage of diabetic neuro-osteoarthropathy ("Charcot foot"). To do this, the affected limb is unloaded and 2.0 to 4.0 ml of platelet-enriched autoplasma is injected into the area of aseptic inflammation and osteodestruction. The number of procedures is from 1 to 3 per a course of treatment of up to 2-3 weeks.
EFFECT: method prevents the development of destruction of the foot osteoarticular apparatus, deformation and plantar ulcer defects formation.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT COMPLICATED DIABETIC NEUROOSTEOARTROPATHIA (CHARCOT'S FOOTSTEP) | 2007 |
|
RU2341221C1 |
| METHOD FOR FUNCTIONAL ARTHRODESIS IN DIABETIC NEUROOSTEOARTHROPATHY (CHARCOT FOOT) | 2015 |
|
RU2604383C2 |
| METHOD FOR TREATMENT OF INITIAL ASEPTIC OSTEONECROSIS OF MIDDLE AND POSTERIOR PARTS OF FOOT DUE TO PATHOLOGICAL FUNCTIONAL RESTRUCTURING OF BONE TISSUE | 2019 |
|
RU2758831C2 |
| METHOD FOR CALCANEAL-TIBIAL ARTHRODESIS IN CHARCOT'S NEUROOSTEOARTHROPATHY | 2022 |
|
RU2782784C1 |
| METHOD FOR TWO-STAGE REPLACEMENT OF TOTAL AND SUBTOTAL FOOT DEFECTS IN CHARCOT ARTHROPATHY | 2022 |
|
RU2776414C1 |
| METHOD FOR KNEE JOINT OSTEOARTHROSIS TREATMENT | 2015 |
|
RU2620495C1 |
| METHOD OF SURGICAL TREATMENT OF OSTEOCHONDRAL INJURIES OF TALUS BLOCK BY METHOD OF MOSAIC AUTOCHONDROPLASTY | 2012 |
|
RU2508060C1 |
| METHOD FOR TWO-STAGE REPLACEMENT OF TOTAL AND SUBTOTAL FOOT DEFECTS IN CHARCOT ARTHROPATHY WITH HETEROTOPIC ALLOGRAFTS USING 3D MODELING | 2022 |
|
RU2787231C1 |
| METHOD FOR THREE-JOINT ARTHRODESIS OF THE FOOT IN PATIENTS WITH SPASTIC CEREBRAL PALSY | 2022 |
|
RU2775136C1 |
| METHOD FOR TREATMENT OF DEGENERATIVE-DYSTROPHIC DISEASES AND LOCOMOTOR SYSTEM INJURIES CONSEQUENCES | 2016 |
|
RU2618928C1 |
